Among patients infected by SARS-CoV-2, individuals with clinical comorbidities represent the group with the highest risk of experiencing a fatal event(5). This finding is especially relevant in societies with an aging population, as the prevalence of pre-existing diseases is higher in older age groups. Existing evidence about age-specific Case-Fatality Rate (CFR) of COVID-19 shows a substantial increase for age groups older than 70 years old. For example, data from China show that CFR for age groups 70-79 and 80 and over to be 8% and 14.8%, respectively. On the contrary, CFR’s fell below the 4% range in younger age groups(6). These age-specific CFRs, in combination with the age-structure of the population, lead to an observed higher number of COVID-19 deaths amongst ages 70 and over in advanced societies(7).